PRINCIPIA BIOPHARMA INC.: eps_diluted
| Value | {"per": "shares", "amount": -0.8, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} |
|---|---|
| Period | 2019-10-01 – 2019-12-31 |
| Status | current |
| Entity | PRINCIPIA BIOPHARMA INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:16.281997+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/eeb6efcf-e4eb-4b50-9cc7-cc251e7f5a33
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-009756 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:16.281997+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510487/eps-diluted/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/eeb6efcf-e4eb-4b50-9cc7-cc251e7f5a33
History
- no predecessors — first report